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  Active serologic surveillance is necessary to control the 
spread of the avian influenza virus (AIV). In this study, we 
evaluated a commercially-available cELISA in terms of its 
ability  to  detect  AIV  antibodies  in  the  sera  of  3,358 
animals from twelve species. cELISA detected antibodies 
against  reference  H1-  through  H15-subtype  AIV  strains 
without  cross  reactivity.  Furthermore,  the  cELISA  was 
able to detect antibodies produced following a challenge of 
the  AIV  H9N2  subtype  in  chickens,  or  following 
v a c c i n a t i o n  o f  t h e  A I V  H 9  o r  H 5  s u b t y p e s  i n  c h i c k e n s ,  
ducks  and  geese.  Next,  we  tested  the  sensitivity  and 
specificity of the cELISA with sera from twelve different 
animal  species,  and  compared  these  results  with  those 
obtained by the hemagglutination-inhibition (HI) test, the 
“gold  standard”  in  AIV  sera  surveillance,  a  second 
commercially-available cELISA (IZS ELISA), or the agar 
gel precipitation (AGP) test. Compared with the HI test, 
the sensitivities and specificities of cELISA were 95% and 
96% in chicken, 86% and 88% in duck, 97% and 100% in 
turkey, 100% and 87% in goose, and 91% and 97% in 
swine, respectively. The sensitivities and specificities of the 
cELISA  in  this  study  were  higher  than  those  of  IZS 
ELISA  for  the  duck,  turkey,  goose,  and  grey  partridge 
sera samples. The results of AGP test against duck and 
turkey  sera  also  showed  significant  correlation  with  the 
results  of  cELISA  (R-value  ＞0.9).  In  terms  of  flock 
sensitivity, the cELISA correlated better with the HI test 
than  with  commercially-available  indirect  ELISAs,  with 
100% flock sensitivity. 
Keywords:  avian influenza virus, competitive ELISA, 
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Introduction 
  The influenza virus is a member of the orthomyxoviridae 
family of RNA viruses, and has three genera - A, B and C. 
Each genus of the virus is further subdivided by serotype 
based upon the surface viral proteins hemagglutinin (HA) 
and neuraminidase (NA). Avian influenza viruses of the 
Influenza A group of viruses only infect birds. Currently, 
16 HA and 9 NA virus subtypes have been described in the 
avian species, and avian influenza viruses with various 
subtype combinations have been isolated [1,2].
  Diagnosing infection with avian influenza virus (AIV) 
can be accomplished in two ways: either through direct 
detection of the virus itself, or through detection of 
antibodies specific for the virus. Direct detection is 
accomplished by isolation of the virion particles, by viral 
antigen detection through immunospecific assays, or by 
targeting viral-specific nucleic acids in the serum of 
suspicious animals. The hemagglutinating inhibition (HI), 
agar gel precipitation (AGP), and virus neutralization tests 
are common serologic tests for AIV employed in the 
diagnostic laboratory [4,7,11,12].
  As the AIVs become widely distributed throughout the 
world, there is an increased need for AIV surveillance and 
tests for AIV vaccine efficacy. The HI test is inexpensive, 
and is therefore the most commonly used test to determine 
the presence of antibodies in the serum to an influenza 
virus [7,13]. However, the HI test requires several 
standardizations and is labor-intensive. Additionally, 
reference sera always need to be included when 
performing the test since minor variations in the epitopes 
of the viral subtypes can result in inaccurate results [12].
    The enzyme-linked immunosorbent assay (ELISA) is 
another option for AIV surveillance and/or evaluation of 
vaccine efficacy. ELISA methods are subdivided based on 324    Dae Sub Song et al.
their approach, and include both indirect and competitive 
methods. The main benefit of the competitive ELISAs 
(cELISAs) over indirect ELISAs in AIV surveillance is 
that indirect ELISAs require the use of species-specific 
enzyme-conjugated antibodies, while cELISAs do not. 
The use of cELISA \eases the testing of sera from various 
species. Several ELISA methods have been developed to 
detect AIV antibodies in animal sera, all of which target the 
common viral proteins of Influenza A viruses [6,8,14,17-19]. 
In addition, previous studies have suggested that cELISAs 
should be effective for large-scale surveillance of AIV in 
avian flocks or herds of other species [17].
  In this study, we addressed whether a specific, commercially- 
available cELISA could be specific and sensitive enough 
for seroepidemiologic or vaccine efficacy studies. The 
seroreactivity of the cELISA were evaluated against sera 
from both avian and non-avian species.
Materials and Methods
Reference sera and viruses 
  The reference sera for AIV subtypes, Newcastle Disease 
virus (NDV), Mycoplasma (M.) gallisepticum, and Egg 
drop syndrome (EDS)-76 virus were provided by the OIE 
AIV Reference Laboratories that validated serum reactivity: 
Instituto Zooprofilattico Sperimentale (IZS) delle Venezie, 
Italy and the Federal Center for Animal Health (ARRIAH), 
Russia. Negative sera from specific pathogen free (SPF) 
chickens were used for the validation of this ELISA in this 
experiment (ND SPF, Korea). 
    The virulent AIV H9N2 strain was provided by the 
National Veterinary Research and Quarantine Service 
(Korea) for the seroconversion test after viral challenge. 
For the checking of seroconversion in seum after influenza 
virus vaccination via intramuscular route, H9N2 and 
H5N1 vaccine strains from the Research Unit of Green 
Cross Veterinary Products (GCVP), Korea and ARRIAH 
of Russia, respectively, were used. 
Serologic tests
    HI and AGP tests were performed according to OIE 
manuals. The overall protocol for the single radial 
hemolysis (SRH) test was performed according with 
guidelines of the Manual of Diagnostic Tests and Vaccines 
for Terrestrial Animals (Equine influenza, part 2-section 
2.5-chapter 2.5.5). The commercially-available cELISA 
evaluated in this study was manufactured by Animal 
Genetics (Korea), and was performed according to the 
manufacturer’s instructions. Briefly, the cELISA plate, 
pre-coated with the viral nucleoprotein (NP) antigen, was 
incubated with an equal mixture of sample and monoclonal 
(anti-NP) HRP-conjugated antibodies for 30 min at 37
oC. 
Following this incubation, all unbound material was 
removed by aspiration and the wells were washed prior to 
addition of a substrate solution. The residual enzyme 
activity in each well was found to be inversely proportional 
to the concentration of anti-NP antibodies in the specimen. 
The results were expressed as the percent inhibition (PI) 
value according to the following formula: 
  PI value = [1-(OD sample/mean OD negative)] × 100
  Based on the PI value and animal species, the samples 
were classified as positive if the PI value was above 50 
(except for turkey, which was considered to be positive for 
PI values ＞ 85), and negative if the PI value was below 49 
(with the exception of turkey, which was negative for PI 
values ＜ 84). 
  A second competitive ELISA (IZS ELISA) was used to 
compare the specificity and sensitivity of the AG cELISA 
with another cELISA method. The IZS ELISA was 
performed according to the manufacturer’s instructions. 
  Indirect ELISA methods, including ProFLOCK Plus AIV 
Ab test kit (Synbiotics, USA), Avivac (ARRIAH, Russia), 
and FlockChek Avian Influenza Antibody Test Kit 
(IDEXX, USA), were performed to compare indirect and 
competitive ELISAs. The indirect ELISA methods were 
performed following the manufacturers’ instructions. 
Seroreactivity test with reference sera
  Seroreactivity tests were performed by two OIE AIV 
reference laboratories, IZS and ARRIAH. H1 to H15 AIV 
subtypes, NDV, EDS-76 virus, and M. gallisepticum were 
each tested against reference sera with cELISA, ProFLOCK, 
and Avivac kits. Negative sera from SPF chickens were 
also included in each test. PI values of each antiserum were 
expressed as the mean value from duplicate tests by each 
laboratory. The samples were classified as having positive 
seroreactivity for PI values greater than 50 (cELISA), 338 
(ProFLOCK), or 15 (Avivac).
Seroconversion test after challenge with AIV H9N2 
strain
    Seroconversion tests following inoculation with the 
virulent AIV H9N2 strain were performed in chickens. 6 
week old SPF chickens were inoculated with 0.2 mL of 
AIV H9N2 strain (10
8.1EID50/0.1 mL) via intranasal (0.1 
mL/chicken) or oral (0.1 mL/chicken) routes. Each 
chicken was raised up to 20 days post-inoculation, and 2 
mL of blood was collected from wing vein at 1 to 2 day 
intervals following AIV challenge. The sera were then 
AIV titer tested by HI and cELISA. 
Seroconversion  test  after  vaccination  with  two 
different avian influenza viruses subtypes
    Seroconversion tests after AIV vaccination were 
performed by 2 laboratories, GCVP of Korea (H9N2) and 
ARRIAH of Russia (H5N1). At GCVP, commercial layer 
hens were vaccinated with an AIV vaccine (GCVP, Korea) 
prepared with an inactivated H9N2 strain (2
10 HA unit/ Evaluation of a competitive ELISA for antibody detection against avian influenza virus    325
Table 1. Seroreactivity with reference sera for avian influenza subtypes
Antisera Subtypes
 cELISA ProFLOCK 
Plus
† Avivac
‡ HI titer AGP
PI value* Results
H1N1
H2N3
H3N8
H4N8
H5N1
H5N2
H5N3
H5N9
H6N2
H7N1
H7N3
H7N7
H8N4
H9N7
H10N1
H11N6
H11N9
H12N5
H13N6
H14N5
H15N9
NDV
EDS-76
M. gallisepticum
SPF
|| chicken serum
A/duck/Italy/1447/05
A/duck/Germany/1215/73
A/psitt/Italy/2873/00
A/cockatoo/England/72
A/mallard/Italy/3401/05
A/turkey/Italy/80
A/duck/Italy/775/04 
A/ckicken/It/22A/98
A/turkey/Canada/65
A/chicken/Italy/1067/99
A/turkey/Italy/9289/02
A/Macaw/626/80 
A/turkey/Ontario/6118/68
A/turkey/Scotland/1/70
A/ostrich/South Africa/01
A/duck/England/56
A/Duck/Memphis/546/174
A/duck/Alberta/60/76
A/gull/Maryland/704/77
A/mallard/Gurjev/263/82
A/wedge-tailed shearwater/Western 
Australia/2576/79
Ulster 2C
Unknown
Unknown
95.5 
89.7 
94.8 
97.4 
96.4 
96.0 
95.0 
97.0 
98.1 
97.8 
95.9 
92.0 
96.1 
95.8 
94.5 
97.7 
97.0 
93.3 
94.9 
96.8 
89.5 
24.0 
10.0 
32.5 
14.0 
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Negative
Negative
Negative
Negative
4,151
9,401
11,263
N.T
§
7,775
11,424
8,727
9,713
N.T
11,673
N.T
11,741
12,273
N.T
N.T
N.T
N.T
11,196
8,937
N.T
N.T
114
101
170
N.T
97
121
258
N.T
87
264
128
92
N.T
227
N.T
239
259
N.T
N.T
N.T
N.T
293
120
N.T
N.T
9
9
10
N.T
1 : 512
1 : 2,048
1 : 32
1 : 512
1 : 512
N.T
N.T
N.T
N.T
N.T
N.T
N.T
1 : 256
1 : 4,096
1 : 64
1 : 128
N.T
1 : 512
1 : 512
1 : 256
1 : 256
＜1 : 2
＜1 : 2
＜1 : 2
＜1 : 2
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Positive
Negative
Negative
Negative
Negative
*Mean percent inhibition (PI) value determined from tests run in duplicate. 
†Positive if the sample was greater than 338.
 ‡Positive if sample
was greater than 15. 
§Not tested. 
||SPF: specific pathogen free.
dose) and aluminum hydroxide gel. The chickens were 
inoculated intramuscularly with 0.5 mL of vaccine per 
chicken, with a boost 2 weeks after the first vaccination 
with same volume of the vaccine. Sera were taken at before 
1 day of prevaccination via wing vein, and at 2 and 4 weeks 
after the first vaccination with the same method of the first 
blood collection. All sera were tested for seroconversion 
by HI and cELISA. 
  At ARRIAH of Russia, chickens, geese and ducks were 
inoculated with an inactivated H5N1 vaccine. The H5N1 
vaccine was produced from strain A/Duck/Novosibirsk/ 
2/05 (2
7 HA unit/dose).
    Chicken sera were taken from wing vein (2 mL of 
blood/each sampling) at 10 and 28 days post-vaccination; 
goose and duck sera were taken at 30 days post-vaccination. 
Chicken sera were tested with HI, cELISA, Indirect ELISA 
(ProFLOCK), and Avivac; goose and duck sera were tested 
with HI and cELISA. The ProFLOCK and Avivac ELISAs 
were in an indirect format that did not allow us to test goose 
or duck. 
Sensitivity and specificity test
  The cELISA was tested with 3,510 sera from diverse 
species, including chicken (n = 1,782), duck (n = 1031), 
turkey (n = 213), goose (n = 25), horse (n = 63), quail (n = 
46), grey partridge (n = 38), red partridge (n = 5), pheasant 
(n = 18), swan (n = 4), guinea fowl (n = 19), and swine (n 
= 266). To determine relative sensitivity and specificity of 
the cELISA, HI (positive, ≥1 : 16), AGP, IZS ELISA, and 
SRH (in the case of horse sera) were compared to results 
obtained by the cELISA. 
Flock sensitivity
  Flock sensitivity was determined from chickens showing 
clinical signs of low pathogenic avian influenza infection, 
with chickens chosen from 12 flocks spread over 10 farms. 326    Dae Sub Song et al.
Fig. 1. Seroconversion tests after avian influenza virus (AIV) 
H9N2 challenge in chickens. The percent inhibition (PI) value 
was determined by cELISA, and a PI value greater than 50 was 
regarded as positive. Seroconversion was detected in 2/5 chickens
4 days post-challenge when tested with cELISA and 1/5 chickens
when tested by the hemagglutination-inhibition (HI) test. The PI 
value and HI titer were mean titers from the cELISA and HI test, 
respectively.
Table 2. Competitive ELISA and hemagglutination-inhibition 
(HI) test results after vaccinating with avian influenza virus 
(AIV) (H9N2) vaccine in chickens
DPI* Group cELISA
† HI test
‡
 0
14
28
Pre-vaccination
Vaccinated
Control
Vaccinated
Control
0/5
§
12/12
0/3
11/11
0/3
0/5
12/12
0/3
11/11
0/3
*Days post-innoculation with AIV H9N2 vaccine. 
†Positive criteria
of cELISA: PI value greater than 50. 
‡Positive criteria of HI test: 
greater than 2
3units. 
§Number of seroconverted layers/ total number 
of layers tested.
Table 3. Results of cELISA, HI test and two indirect ELISAs 
after vaccinating with AIV (H5N1) vaccine in chickens, geese 
and ducks
Species D.P.I* cELISA
† Indirect 
ELISA (A)
‡
Indirect 
ELISA (B)
§ HI test
||
Chickens
Geese
Ducks
10
28
30
30
 5/5
¶
5/5
8/8
4/5
5/5
5/5
    N.T**
N.T
4/5
5/5
N.T
N.T
1/5
5/5
4/8
2/5
*Days post inoculation with AIV H5N1 vaccine. 
†Positive criteria of
competitive ELISA: PI value greater than 50. 
‡Positive criteria of 
indirect ELISA (A): greater than 337. 
§Positive criteria of indirect 
ELISA (B): greater than 14. 
||Positive criteria of HI test: greater than 
23 units. 
¶Number of the seroconverted animals/ total number of 
animals tested. **Indirect ELISA could not be used to test goose or 
duck sera.
Antibody titers from these sera were analyzed with HI (H9 
antigen used), cELISA, and a commercially-available 
indirect ELISA kit.
Data analysis and statistics
    All data analysis and statistics about sensitivity, 
specificity, and R-value were performed using Microsoft 
Offiece Excel 2007 program (Microsoft, USA). 
Results
Seroreactivity with reference sera
    cELISA successfully detected antibodies against the 
following avian influenza virus strains: H1N1, H2N3, 
H3N8, H4N8, H5N1, H5N2, H5N3, H5N9, H6N2, H7N1, 
H7N3, H7N7, H8N4, H9N7, H10N1, H11N6, H11N9, 
H12N5, H13N6, H14N5, and H15N9. No cross-reactivity 
was observed with antibodies against NDV, EDS-76 virus, 
M. gallisepticum, or SPF chicken serum (Table 1). Indirect 
ELISAs were not applicable to any reference sera other 
than chicken (data was not shown), due to the requirement 
of species-specificity conjugates. 
Seroconversion after AIV challenge
    Seroconversion was detected by cELISA 4 days 
post-challenge in 2 out of the 5 chickens. The HI test 
(positive result for titers ＞ 2
3) detected seroconversion in 
only 1 of the 5 chickens by day 4. At six days post-challenge, 
both tests revealed that all chickens had seroconverted to 
AIV H9N2. When the viral titer was lowered to 
10
4.5EID50/0.1 mL for intranasal inoculation, seroconversion 
was also detected within 4 days post-challenge (date not 
shown). The patterns of serum antibody titers with cELISA 
and HI test are presented in Fig. 1.
Seroconversion test after inactivated AIV vaccine 
inoculation
    All chickens vaccinated with inactivated AIV H9N2 
vaccine seroconverted according to the cELISA within 14 
days post-vaccination, while all the non-vaccinated birds 
maintained their seronegative status. This result was in 
agreement with results obtained by HI test (Table 2).
  In the experiment with AIV H5N1 vaccination, all the 
chickens seroconverted by 10 days post-vaccination 
according to cELISA, while only 1 of 5 chickens tested 
seroconverted by 10 days with the HI test. Twentry-eight 
days post-vaccination, all inoculated chickens had 
seroconverted according to either the cELISA or HI test. 
The results from indirect ELISA methods showed Evaluation of a competitive ELISA for antibody detection against avian influenza virus    327
Table 4. Sensitivity and specificity of cELISA in diverse species
Species
HI IZS ELISA AGP/RSH
Sensitivity Specificity Sensitivity Specificity Sensitivity Specificity
Chicken 
(n = 1,782*)
362
†, 1,420
‡ 　NT
§ 　NT NT NT
97% 94% 　　　　
Duck 
(n = 1,031
||)
86
†, 92
‡ 81
†, 97
‡ AGP (152
†, 701
‡)
86% 88% 98% 94% 　100% 100%
Turkey 
(n = 213)
108
†, 105
‡ 108
†, 105
‡ AGP (108
†, 105
‡)
97% 100% 97% 100% 97% 100%
Goose
(n = 25)
10
†, 15
‡ 12, 13
‡ NT NT
100% 87% 100% 100% 　　
Horse 
(n = 63)
　NT  　NT  　NT  　NT RSH  (63
†, 0
‡)
　　　　 100% NT
Quail 
(n = 46)
13
†, 33
‡ 5
†, 41
‡ 　NT NT
100% 97% 100% 78% 　　
Grey partridge 
(n = 38)
4
†, 34
‡ 5
†, 33
‡ 　NT NT
75% 94% 100% 100% 　　
Red Partridge
(n = 5)
0
†, 5
‡ 0
†, 5
‡ 　NT NT
NT 100% NT 100% 　　
Pheasant 
(n = 18)
9
†, 9
‡ 10
†, 8
‡ 　NT NT
100% 67% 100% 75% 　　
Swan 
(n = 4)
4
†, 0
‡ 2
†, 2
‡ 　NT NT
50% NT 100% 100% 　　
Guinea Fowl 
(n = 19)
8
†, 11
‡ 8
†, 11
‡ 　NT NT
88% 100% 88% 100% 　　
Swine
(n = 266)
190
†, 76
‡ 　NT  　NT  　NT NT
91% 97% 　　　
*Total number of sera tested. 
†Number of positively tested sera. 
‡Number of negatively tested sera. 
§Not tested. 
||Sera for HI and IZS ELISA 
were from Italy, and sera for AGP were from Korea.
significant correlation with the chicken cELISA results (R 
value ＞ 0.9). The sera from geese and ducks also showed 
seroconversion compared with pre-immune sera at 30 days 
post-vaccination when tested by cELISA, but only 4 of the 
8 geese, and 2 of the 5 ducks showed seroconversion by HI 
test (Table 3). 
Specificity and sensitivity test in variable species
  The cELISA was tested with 3,358 sera originating from 
various species, including chicken, duck, turkey, goose, 
horse, quail, grey partridge, red partridge, pheasant, swan, 
guinea fowl, and swine. The cELISA results were compared 
against those obtained via HI, IZS ELISA, AGP, and SRH. 
The overall sensitivity and specificity results for these 
diverse species are presented on Table 4.
    Considering the HI as the “gold standard” for 
seroconversion testing, the sensitivity and specificity for 
the cELISA as compared with the HI test were 95% and 
96% in chicken, 86% and 88% in duck, 97% and 100% in 
turkey, 100% and 87% in goose, and 91% and 97% in 
swine, respectively. Both the sensitivity and specificity of 
the cELISA increased when compared with IZS ELISA in 
the duck, turkey, goose, and grey partridge sera samples. 
The results of AGP test against duck and turkey sera also 
showed significant correlation (R value ＞ 0.9) with the 
results of cELISA. In the red partridge and swan, the 
number of sera tested was too low to calculate specificity 
or sensitivity with any significance. Only positive samples 
of the horse sera were evaluated, and these were in 100% 328    Dae Sub Song et al.
Table 5. Flock sensitivity of competitive ELISA in the low 
pathogenic AIV- infected farms in Korea
Flock ID
Positive samples/Total examined samples*
HI test 
against H9
Indirect 
ELISA
Competitive 
ELISA
CK-CC
CK-SH
HN-B
JYO
NO-2
NS-1
NS-2
NS-F
NW-2
SH
WOM-CC
YM-2
1/3
2/4
4/4
6/8
4/4
1/3
5/8
4/7
6/6
11/11
2/3
1/2
2/3
1/4
1/4
5/8
1/4
1/3
4/8
5/7
4/6
  8/11
2/3
1/2
3/3
2/4
3/4
7/8
4/4
1/3
7/8
6/7
6/6
11/11
3/3
2/2
*Tested samples were obtained from chickens that showed clinical 
signs of low pathogenic AI.
agreement. 
Flock sensitivity
    All 12 flocks had a positive reaction against avian 
influenza virus, as determined by HI titer or ELISA. 
Specially, the cELISA correlated with the HI test better 
than the commercially-available indirect ELISAs, with 
100% flock sensitivity (Table 5).
Discussion
  There are many methods available for detecting avian 
influenza viral antigens or antibodies in the sera of animals. 
Antigen-capture ELISAs targeting AIV NP [3], and 
RT-PCR-based methods have been developed [5,9,16] for 
virus identification. However, because influenza viruses 
can clear the bloodstream within one week of clinical signs 
of infection, antigen detection methods have a short 
window of efficacy in the large-scale surveillance of herds 
[3]. Therefore, tests for influenza virus antibodies are 
preferred for flock surveillance, particularly in large 
population systems like chickens, swine and other avian 
livestock [16]. The AGP test is one method used to test for 
all influenza virus type A-specific antibodies, but this test 
has several disadvantages, including low sensitivity and a 
long processing time for test results [10,15]. The 
competitive ELISA method may be a useful and effective 
method for the avian influenza surveillance system.
  Based on our results monitoring serum antibody titers 
after viral challenge and vaccination, seroconversion 
detection time was adequate when using cELISA compared 
to the HI test. Furthermore, the overall patterns of serum 
antibody titers demonstrated that competitive ELISA is 
more sensitive than the HI test. These seroconversion and 
sensitivity results indicate that the competitive ELISA 
method could be used to study seroepidemiology of 
diverse influenza viruses. 
    The cELISA results for reference sera were in close 
agreement with those from the HI test, suggesting that that 
cELISA could detect avian influenza virus antibodies with 
high fidelity and sensitivity. Optimal sensitivity and 
specificity of the cELISA compared to the HI test or IZS 
ELISA were also obtained from the sera of multiple species, 
including chickens, ducks, geese, guinea fowl, grey 
partridge and swine. In other avian species (specifically, 
turkeys, quails and pheasants), the sensitivity of the 
cELISA was high, but specificity was relatively low. This 
may indicate that the cELISA should be performed for 
surveillance, followed by a conventional standard test 
when specific species need to be tested.
  A high degree of sensitivity for AIV detection in positive 
flocks was also displayed by the cELISA. cELISA detected 
positive sera with more sensitivity than either the HI test or 
indirect ELISA. With its high agreement with the HI test in 
the reference sera and the flock sensitivity test, cELISA 
could be used to conveniently and quickly screen the avian 
influenza status of a chicken flock.
  Antigenic drift, shift, and re-assortment make it realistic 
that the avian influenza virus could become infective to a 
new species. An ideal influenza surveillance system would 
permit testing of diverse species. The cELISA evaluated in 
this study showed high detection sensitivity to antibodies 
from diverse influenza types across various species. This 
commercially-available cELISA could therefore be used 
for large-scale surveillance of various species to predict 
and prevent influenza outbreaks, especially in chickens, 
ducks and swine. 
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